Old Web
English
Sign In
Acemap
>
Paper
>
Angiotensin II treatment in COVID-19 patients: more risk than benefit? A single-center experience.
Angiotensin II treatment in COVID-19 patients: more risk than benefit? A single-center experience.
2020
Ulrike Heinicke
Elisabeth Hannah Adam
Michael Sonntagbauer
Andreas von Knethen
Kai Zacharowski
Holger Neb
Keywords:
Single Center
Emergency medicine
Angiotensin II
Medicine
Coronavirus disease 2019
severe acute respiratory syndrome coronavirus 2
Intensive care medicine
2019 20 coronavirus outbreak
Correction
Source
Cite
Save
Machine Reading By IdeaReader
5
References
0
Citations
NaN
KQI
[]